Share：
Share this content in WeChat
X
[Chinese][PDF]51
• Review •
Advances in MRI studies of lymphvascular space invasion in endometrial carcinoma
HAN Ying  SUN Meiyu 

Cite this article as: HAN Y, SUN M Y. Advances in MRI studies of lymphvascular space invasion in endometrial carcinoma[J]. Chin J Magn Reson Imaging, 2024, 15(7): 216-220, 234. DOI:10.12015/issn.1674-8034.2024.07.036.


[Abstract] Endometrial carcinoma (EC) is a common malignant tumor of female reproductive tract, the incidence of EC is increasing year by year in recent years. Lymphvascular space invasion (LVSI) is considered to be an independent risk factor for pelvic lymph node metastasis in early EC patients, which seriously affects the prognosis of patients. The accurate assessment of LVSI before surgery is helpful to guide the selection of individualized surgical methods. Conventional MRI is limited to evaluating LVSI based on morphology, whereas MRI functional sequences can assess LVSI status using quantitative parameters. This paper introduces the clinical value of MRI sequences in the diagnosis and evaluation of LVSI in EC, aiming to conduct a review by analyzing recent domestic and international literature, summarize LVSI evaluation by multimodal MRI in EC. To provide an objective imaging basis for evaluating LVSI by multimodal MRI.
[Keywords] endometrial cancer；lymphatic vascular space infiltration；magnetic resonance imaging；multimodality；diffusion weighted imaging；amide proton transfer weighted；enhanced T2 star-weighted angiography

HAN Ying   SUN Meiyu*  

Department of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China

Corresponding author: SUN M Y, E-mail: sunmy828@126.com

Conflicts of interest   None.

Received  2024-03-14
Accepted  2024-07-08
DOI: 10.12015/issn.1674-8034.2024.07.036
Cite this article as: HAN Y, SUN M Y. Advances in MRI studies of lymphvascular space invasion in endometrial carcinoma[J]. Chin J Magn Reson Imaging, 2024, 15(7): 216-220, 234. DOI:10.12015/issn.1674-8034.2024.07.036.

[1]
BROOKS R A, FLEMING G F, LASTRA R R, et al. Current recommendations and recent progress in endometrial cancer[J]. CA Cancer J Clin, 2019, 69(4): 258-279. DOI: 10.3322/caac.21561.
[2]
SIEGEL R, GIAQUINTO A N, JEMAL A. Cancer statistics, 2024[J]. CA A Cancer J Clin, 2024, 74: 12-49. DOI: 10.3322/caac.21820.
[3]
GUMTORNTIP P, POOMTAVORN Y, TANPRASERTKUL C. Predicting factors for pelvic lymph node metastasis in patients with apparently early-stage endometrial cancer[J]. Asian Pac J Cancer Prev, 2022, 23(2): 617-622. DOI: 10.31557/APJCP.2022.23.2.617.
[4]
LONG L, SUN J Q, JIANG L L, et al. MRI-based traditional radiomics and computer-vision nomogram for predicting lymphovascular space invasion in endometrial carcinoma[J]. Diagn Interv Imaging, 2021, 102(7/8): 455-462. DOI: 10.1016/j.diii.2021.02.008.
[5]
QIN Z J, WANG Y S, CHEN Y L, et al. Evaluation of prognostic significance of lymphovascular space invasion in early stage endometrial cancer: a systematic review and meta-analysis[J/OL]. Front Oncol, 2023, 13: 1286221 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/38273843/. DOI: 10.3389/fonc.2023.1286221.
[6]
FENG J, ZHANG Y, HUANG C Z, et al. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: a multicenter study[J/OL]. Eur J Surg Oncol, 2024, 50(4): 108261 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/38484494/. DOI: 10.1016/j.ejso.2024.108261.
[7]
HAN L, CHEN Y L, ZHENG A, et al. Prognostic value of three-tiered scoring system for lymph-vascular space invasion in endometrial cancer: a systematic review and meta-analysis[J]. Gynecol Oncol, 2024, 184: 198-205. DOI: 10.1016/j.ygyno.2024.01.046.
[8]
PETERS E E M, LÉON-CASTILLO A, HOGDALL E, et al. Substantial lymphovascular space invasion is an adverse prognostic factor in high-risk endometrial cancer[J]. Int J Gynecol Pathol, 2022, 41(3): 227-234. DOI: 10.1097/PGP.0000000000000805.
[9]
TORTORELLA L, RESTAINO S, ZANNONI G F, et al. Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer[J/OL]. J Gynecol Oncol, 2021, 32(2): e11 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/33470061/. DOI: 10.3802/jgo.2021.32.e11.
[10]
SUN Y, WANG Y P, CHENG X R, et al. Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer[J/OL]. Eur J Surg Oncol, 2024, 50(4): 108260 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/38484492/. DOI: 10.1016/j.ejso.2024.108260.
[11]
AYHAN A, ŞAHIN H, SARI M E, et al. Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer[J]. Int J Gynecol Cancer, 2019, 29(3): 505-512. DOI: 10.1136/ijgc-2018-000069.
[12]
OLIVER-PEREZ M R, PADILLA-ISERTE P, ARENCIBIA-SANCHEZ O, et al. Lymphovascular space invasion in early-stage endometrial cancer (LySEC): patterns of recurrence and predictors. A multicentre retrospective cohort study of the Spain gynecologic oncology group[J/OL]. Cancers, 2023, 15(9): 2612 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/37174081/. DOI: 10.3390/cancers15092612.
[13]
BEREBY-KAHANE M, DAUTRY R, MATZNER-LOBER E, et al. Prediction of tumor grade and lymphovascular space invasion in endometrial adenocarcinoma with MR imaging-based radiomic analysis[J]. Diagn Interv Imaging, 2020, 101(6): 401-411. DOI: 10.1016/j.diii.2020.01.003.
[14]
LAVAUD P, FEDIDA B, CANLORBE G, et al. Preoperative MR imaging for ESMO-ESGO-ESTRO classification of endometrial cancer[J]. Diagn Interv Imaging, 2018, 99(6): 387-396. DOI: 10.1016/j.diii.2018.01.010.
[15]
NOUGARET S, REINHOLD C, ALSHARIF S S, et al. Endometrial cancer: combined MR volumetry and diffusion-weighted imaging for assessment of myometrial and lymphovascular invasion and tumor grade[J]. Radiology, 2015, 276(3): 797-808. DOI: 10.1148/radiol.15141212.
[16]
KELES D K, EVRIMLER S, MERD N, et al. Endometrial cancer: the role of MRI quantitative assessment in preoperative staging and risk stratification[J]. Acta Radiol, 2022, 63(8): 1126-1133. DOI: 10.1177/02841851211025853.
[17]
LUO Y, MEI D D, GONG J S, et al. Multiparametric MRI-based radiomics nomogram for predicting lymphovascular space invasion in endometrial carcinoma[J]. J Magn Reson Imaging, 2020, 52(4): 1257-1262. DOI: 10.1002/jmri.27142.
[18]
WANG Y D, LIU W, LU Y Y, et al. Fully automated identification of lymph node metastases and lymphovascular invasion in endometrial cancer from multi-parametric MRI by deep learning[J/OL]. J Magn Reson Imaging, 2024 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/38471960/. DOI: 10.1002/jmri.29344.
[19]
QI W Y, CHENG Y, YANG S G. Value of diffusion-weighted imaging in evaluating lymphovascular space invasion of endometrial cancer[J]. Radiol Pract, 2021, 36(2): 222-226. DOI: 10.13609/j.cnki.1000-0313.2021.02.014.
[20]
RAFIEE A, MOHAMMADIZADEH F. Association of lymphovascular space invasion (LVSI) with histological tumor grade and myometrial invasion in endometrial carcinoma: a review study[J/OL]. Adv Biomed Res, 2023, 12: 159 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/37564444/. DOI: 10.4103/abr.abr_52_23.
[21]
TAŞKUM İ, BADEMKıRAN M H, ÇETIN F, et al. A novel predictive model of lymphovascular space invasion in early-stage endometrial cancer[J]. Turk J Obstet Gynecol, 2024, 21(1): 37-42. DOI: 10.4274/tjod.galenos.2024.92597.
[22]
MA X L, REN X J, SHEN M H, et al. Volumetric ADC histogram analysis for preoperative evaluation of LVSI status in stage I endometrioid adenocarcinoma[J]. Eur Radiol, 2022, 32(1): 460-469. DOI: 10.1007/s00330-021-07996-6.
[23]
YAN B C, XIAO M L, LI Y, et al. The diagnostic performance of ADC value for tumor grade, deep myometrial invasion and lymphovascular space invasion in endometrial cancer: a meta-analysis[J/OL]. Acta Radiol, 2019: 284185119841988 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/31042066/. DOI: 10.1177/0284185119841988.
[24]
LE BIHAN D. What can we see with IVIM MRI?[J]. NeuroImage, 2019, 187: 56-67. DOI: 10.1016/j.neuroimage.2017.12.062.
[25]
WANG C Y. Diagnostic value of multimodal MR imaging in histological classification of endometrial carcinoma and lymphatic vascular space infiltration[D].Dalian: Dalian Medical University, 2020.
[26]
ZHANG Q, OUYANG H, YE F, et al. Multiple mathematical models of diffusion-weighted imaging for endometrial cancer characterization: correlation with prognosis-related risk factors[J/OL]. Eur J Radiol, 2020, 130: 109102 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/32673928/. DOI: 10.1016/j.ejrad.2020.109102.
[27]
WANG F, LIU Y, ZHANG Y W, et al. The diagnostic value of multi-modal diffusion MR imaging in differentiating lymphatic vascular space invasion of early-stage endometrial carcinoma[J]. J Clin Radiol, 2022, 41(2): 293-298. DOI: 10.13437/j.cnki.jcr.2022.02.025.
[28]
JIN X X, YAN R F, LI Z, et al. Evaluation of amide proton transfer-weighted imaging for risk factors in stage I endometrial cancer: a comparison with diffusion-weighted imaging and diffusion kurtosis imaging[J/OL]. Front Oncol, 2022, 12: 876120 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/35494050/. DOI: 10.3389/fonc.2022.876120.
[29]
YAMADA I, SAKAMOTO J, KOBAYASHI D, et al. Diffusion kurtosis imaging of endometrial carcinoma: correlation with histopathological findings[J]. Magn Reson Imaging, 2019, 57: 337-346. DOI: 10.1016/j.mri.2018.12.009.
[30]
MENG N, FANG T, FENG P Y, et al. Amide proton transfer-weighted imaging and multiple models diffusion-weighted imaging facilitates preoperative risk stratification of early-stage endometrial carcinoma[J]. J Magn Reson Imaging, 2021, 54(4): 1200-1211. DOI: 10.1002/jmri.27684.
[31]
CHEN T, LI Y, LU S S, et al. Quantitative evaluation of diffusion-kurtosis imaging for grading endometrial carcinoma: a comparative study with diffusion-weighted imaging[J/OL]. Clin Radiol, 2017, 72(11): 995.e11-e20 [2024-06-20]. https://pubmed.ncbi.nlm.nih.gov/28774471/. DOI: 10.1016/j.crad.2017.07.004.
[32]
SONG J C, LU S S, ZHANG J, et al. Quantitative assessment of diffusion kurtosis imaging depicting deep myometrial invasion: a comparative analysis with diffusion-weighted imaging[J]. Diagn Interv Radiol, 2020, 26(2): 74-81. DOI: 10.5152/dir.2019.18366.
[33]
TIAN S F, MENG X, ZHU W, et al. Amide proton transfer weighted and diffusion kurtosis imaging in evaluating lymphovascular space invasion of endometrial carcinoma[J]. Chin J Med Imag, 2023, 31(10): 1085-1089. DOI: 10.3969/j.issn.1005-5185.2023.10.016.
[34]
ZHAO J F, CAO X S. Research progress of radiomics based on multi-parameter MRI in lymphatic space invasion of endometrial cancer[J]. Chin J Magn Reson Imag, 2023, 14(6): 171-175. DOI: 10.12015/issn.1674-8034.2023.06.031.
[35]
MEYER H J, HAMERLA G, LEIFELS L, et al. Histogram analysis parameters derived from DCE-MRI in head and neck squamous cell cancer - Associations with microvessel density[J/OL]. Eur J Radiol, 2019, 120: 108669 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/31542700/. DOI: 10.1016/j.ejrad.2019.108669.
[36]
HU Y, ZHANG Y, CHENG J L. Diagnostic value of molybdenum target combined with DCE-MRI in different types of breast cancer[J]. Oncol Lett, 2019, 18(4): 4056-4063. DOI: 10.3892/ol.2019.10746.
[37]
WANG H X, YAN R F, LI Z, et al. Quantitative dynamic contrast-enhanced parameters and intravoxel incoherent motion facilitate the prediction of TP53 status and risk stratification of early-stage endometrial carcinoma[J]. Radiol Oncol, 2023, 57(2): 257-269. DOI: 10.2478/raon-2023-0023.
[38]
JAMIESON A, THOMPSON E F, HUVILA J, et al. p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification[J]. Int J Gynecol Cancer, 2021, 31(6): 907-913. DOI: 10.1136/ijgc-2020-002256.
[39]
YUE X N, HE X Y, WU J J, et al. Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker HE4 to evaluate tumour grade and lymphovascular space invasion[J]. Clin Radiol, 2023, 78(8): e574-e581 [2024-06-20]. https://pubmed.ncbi.nlm.nih.gov/37183140/. DOI: 10.1016/j.crad.2023.04.005.
[40]
OPLAWSKI M, DZIOBEK K, ZMARZŁY N, et al. Expression profile of VEGF-C, VEGF-D, and VEGFR-3 in different grades of endometrial cancer[J]. Curr Pharm Biotechnol, 2019, 20(12): 1004-1010. DOI: 10.2174/1389201020666190718164431.
[41]
LI Y J, CONG P S, WANG P, et al. Risk factors for pelvic lymph node metastasis in endometrial cancer[J]. Arch Gynecol Obstet, 2019, 300(4): 1007-1013. DOI: 10.1007/s00404-019-05276-9.
[42]
PANYAVARANANT P, MANCHANA T. Preoperative markers for the prediction of high-risk features in endometrial cancer[J]. World J Clin Oncol, 2020, 11(6): 378-388. DOI: 10.5306/wjco.v11.i6.378.
[43]
ZHUO Z Z, QU L Y, ZHANG P, et al. Prediction of H3K27M-mutant brainstem glioma by amide proton transfer-weighted imaging and its derived radiomics[J]. Eur J Nucl Med Mol Imaging, 2021, 48(13): 4426-4436. DOI: 10.1007/s00259-021-05455-4.
[44]
OHNO Y, YUI M, KOYAMA H, et al. Chemical exchange saturation transfer MR imaging: preliminary results for differentiation of malignant and benign thoracic lesions[J]. Radiology, 2016, 279(2): 578-589. DOI: 10.1148/radiol.2015151161.
[45]
ABBINK K, ZUSTERZEEL P L M, GEURTS-MOESPOT A, et al. Prognostic significance of VEGF and components of the plasminogen activator system in endometrial cancer[J]. J Cancer Res Clin Oncol, 2020, 146(7): 1725-1735. DOI: 10.1007/s00432-020-03225-7.
[46]
HAN X, SUN M Y, WANG M Y, et al. The enhanced T2 star weighted angiography (ESWAN) value for differentiating borderline from malignant epithelial ovarian tumors[J]. Eur J Radiol, 2019, 118: 187-193. DOI: 10.1016/j.ejrad.2019.07.011.
[47]
TIAN S F, LIU A L, ZHU W, et al. The value of multiple quantitative parameters of diffusion kurtosis imaging sequence to evaluate the expression of Ki-67 in endometrial carcinoma: a preliminary study[J]. J China Clin Med Imag, 2018, 29(11): 808-813. DOI: 10.12117/jccmi.2018.11.010.
[48]
FENG W, LIU X R, LU X R, et al. Progress in the application of different functional magnetic resonance imaging techniques in breast cancer[J]. Chin J Magn Reson Imag, 2024, 15(1): 217-223. DOI: 10.12015/issn.1674-8034.2024.01.037.
[49]
WANG Y A, HE M G, CAO P, et al. Tissue characteristics of endometrial carcinoma analyzed by quantitative synthetic MRI and diffusion-weighted imaging[J]. Diagnostics, 2022, 12(12): 2956 [2024-06-04]. https://pubmed.ncbi.nlm.nih.gov/36552962/. DOI: 10.3390/diagnostics12122956.
[50]
SIEGENTHALER F, EPSTEIN E, BÜCHI C A, et al. Prognostic value of lymphovascular space invasion according to the molecular subgroups in endometrial cancer[J]. Int J Gynecol Cancer, 2023, 33(11): 1702-1707. DOI: 10.1136/ijgc-2023-004606.

PREV Progress of quantitative prediction of the pathologic complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer with functional MRI
NEXT Research progress of radiomics in the treatment of ovarian cancer
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn